News

New

Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement

Story, Leadership 05 June 2025

Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US

Press Release, Product 05 June 2025

Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable

Press Release, Corporate 29 May 2025

Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...

Press Release, Product 27 May 2025

New

Hikma announces strong medium-term Group guidance ahead of its US site visit

Press Release, Corporate 15 May 2025

New

Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits

Press Release, Corporate 08 May 2025

S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

Press Release, Corporate 08 May 2025

Hikma reiterates full year guidance following good start to the year

Press Release, Corporate 24 April 2025

Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France

Insight, Life at Hikma 17 April 2025

Hikma acquires Novugen’s FDA-approved ANDA for trametinib

Press Release, Product 17 April 2025

Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA

Press Release, Business Development 09 April 2025

New

Hikma launches Cisatracurium Besylate Injection, USP in the US

Press Release, Product 25 March 2025

New

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Press Release, Product 20 March 2025

New

Developing our pipeline in growing therapeutic areas

Story, Corporate 19 March 2025

New

Focusing on our quality manufacturing